[1]
D. K. Dwi, R. Sasongkowati, and E. Haryanto, “STUDI IN SILICO SIFAT FARMAKOKINETIK, TOKSISITAS, DAN AKTIVITAS IMUNOMODULATOR BRAZILEIN KAYU SECANG TERHADAP ENZIM 3-CHYMOTRYPSIN-LIKE CYSTEINE PROTEASE CORONAVIRUS”, JoIMedLabS, vol. 1, no. 1, pp. 76-85, Oct. 2020.